The Use of Darunavir/Ritonavir as Intensification in Low Viremic HIV-Infected Patients Treated with Boosted Protease Inhibitor-Containing Regimens

Sungkanuparph S. , Groger RK , Overton ET , Fraser VJ , Powderly WG Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy. HIV Med. 2006;7: 437-441.

US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Available at: http://aidsinfo.nih.gov/ContentFiles/AboutHIVTreatmentGuidelines_FS_en.pdf . Accessed September 14, 2008.

Hammer S. , Saag M. , Schechter M. , et al. Treatment for adult HIV infection: 2006 recommendations of the international AIDS Society-USA Panel. JAMA. 2006;296: 827-843.

Sturmer M. , Dauer B. , Moesch M. , et al. Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/ abacavir as a first-line regimen. Antivir Ther. 2007;12: 25-30.

Lafeuillade A. , Hittinger G. , Delbeke E. , Poggi C. Resistance selection in patients with stable low levels of HIV-1 viremia. Presented at: The 15th International AIDS conference; July 11-16, 2004; Bangkok, Thailand. Abstract WeOrB1293.

Cozzi-Lepri A. , Philips AN , Ruiz L. , et al. Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen. AIDS. 2007;21:721-732.